Hereditary angioedema - therapeutic trends

[1]  T. Craig,et al.  Perioperative management for patients with hereditary angioedema , 2015, Allergy & rhinology.

[2]  M. Triggiani,et al.  Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.

[3]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[4]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[5]  H. Farkas.  Pediatric hereditary angioedema due to C1-inhibitor deficiency , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[6]  K. Bork,et al.  Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. , 2009, The Journal of allergy and clinical immunology.

[7]  T. Craig,et al.  When is prophylaxis for hereditary angioedema necessary? , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  M. Cicardi,et al.  C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.

[9]  K. Bork,et al.  Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.

[10]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[11]  A. Davis.  The pathophysiology of hereditary angioedema. , 2005, Clinical immunology.